Galderma Settles Pimple Drug Patent Suit With Par
Swiss skincare company Galderma SA and Par Pharmaceutical Inc. told a Texas federal court Friday they had reached a settlement over allegations that the generics maker sought to market a knockoff...To view the full article, register now.
Already a subscriber? Click here to view full article